Mercurial > repos > davidvanzessen > shm_csr
annotate shm_overview.htm @ 98:d714f5ea83d7 draft default tip
planemo upload commit 1a01065a084a817382872154f779b94090a35ebf
author | rhpvorderman |
---|---|
date | Wed, 10 Jan 2024 12:32:47 +0000 |
parents | 6809c63d9161 |
children |
rev | line source |
---|---|
67 | 1 <html> |
2 | |
3 <head> | |
90
6809c63d9161
"planemo upload commit fd64827ff6e63df008f6f50ddb8576ad2b1dbb26"
rhpvorderman
parents:
67
diff
changeset
|
4 <meta http-equiv=Content-Type content="text/html; charset=UTF-8"> |
67 | 5 <meta name=Generator content="Microsoft Word 14 (filtered)"> |
6 <style> | |
7 <!-- | |
8 /* Font Definitions */ | |
9 @font-face | |
10 {font-family:Calibri; | |
11 panose-1:2 15 5 2 2 2 4 3 2 4;} | |
12 /* Style Definitions */ | |
13 p.MsoNormal, li.MsoNormal, div.MsoNormal | |
14 {margin-top:0in; | |
15 margin-right:0in; | |
16 margin-bottom:10.0pt; | |
17 margin-left:0in; | |
18 line-height:115%; | |
19 font-size:11.0pt; | |
20 font-family:"Calibri","sans-serif";} | |
21 .MsoChpDefault | |
22 {font-family:"Calibri","sans-serif";} | |
23 .MsoPapDefault | |
24 {margin-bottom:10.0pt; | |
25 line-height:115%;} | |
26 @page WordSection1 | |
27 {size:8.5in 11.0in; | |
28 margin:1.0in 1.0in 1.0in 1.0in;} | |
29 div.WordSection1 | |
30 {page:WordSection1;} | |
31 --> | |
32 </style> | |
33 | |
34 </head> | |
35 | |
36 <body lang=EN-US> | |
37 | |
38 <div class=WordSection1> | |
39 | |
40 <p class=MsoNormalCxSpFirst style='text-align:justify'><b><span lang=EN-GB | |
41 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Info | |
42 table</span></b></p> | |
43 | |
44 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | |
45 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>This | |
46 table contains information on different characteristics of SHM. For all | |
47 characteristics information can be found for all sequences or only sequences of | |
48 a certain (sub)class. All results are based on the sequences that passed the filter | |
49 settings chosen on the start page of the SHM & CSR pipeline and only | |
50 include details on the analysed region as determined by the setting of the | |
51 sequence starts at filter. All data in this table can be downloaded via the | |
90
6809c63d9161
"planemo upload commit fd64827ff6e63df008f6f50ddb8576ad2b1dbb26"
rhpvorderman
parents:
67
diff
changeset
|
52 “downloads” tab.</span></p> |
67 | 53 |
54 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | |
55 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Mutation | |
56 frequency:</span></u></p> | |
57 | |
58 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK83"></a><a | |
59 name="OLE_LINK82"></a><a name="OLE_LINK81"><span lang=EN-GB style='font-size: | |
60 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These values | |
61 give information on the level of SHM. </span></a><a name="OLE_LINK22"></a><a | |
62 name="OLE_LINK21"></a><a name="OLE_LINK20"><span lang=EN-GB style='font-size: | |
63 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>More information | |
64 on the values found in healthy individuals of different ages can be found in </span></a><a | |
65 name="OLE_LINK15"></a><a name="OLE_LINK14"></a><a name="OLE_LINK13"><span | |
66 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>IJspeert | |
67 and van Schouwenburg et al, PMID: 27799928</span></a></p> | |
68 | |
69 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
70 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Number | |
71 of mutations:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height: | |
72 115%;font-family:"Times New Roman","serif"'> Shows the number of total | |
73 mutations / the number of sequenced bases (the % of mutated bases).</span></p> | |
74 | |
75 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
76 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Median | |
77 number of mutations:</span></i><span lang=EN-GB style='font-size:12.0pt; | |
78 line-height:115%;font-family:"Times New Roman","serif"'> Shows the median % of | |
79 SHM of all sequences.</span></p> | |
80 | |
81 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | |
82 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Patterns | |
83 of SHM:</span></u></p> | |
84 | |
85 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK72"></a><a | |
86 name="OLE_LINK71"></a><a name="OLE_LINK70"><span lang=EN-GB style='font-size: | |
87 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These values | |
88 give insights into the targeting and patterns of SHM. These values can give | |
89 insight into the repair pathways used to repair the U:G mismatches introduced | |
90 by AID. </span></a><a name="OLE_LINK40"></a><a name="OLE_LINK39"></a><a | |
91 name="OLE_LINK38"></a><a name="OLE_LINK60"><span lang=EN-GB style='font-size: | |
92 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>More information | |
93 on the values found in healthy individuals of different ages can be found in | |
94 IJspeert and van Schouwenburg et al, PMID: 27799928</span></a></p> | |
95 | |
96 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
97 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions:</span></i><span | |
98 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
99 Shows the number of transition mutations / the number of total mutations (the | |
100 percentage of mutations that are transitions). Transition mutations are C>T, | |
101 T>C, A>G, G>A. </span></p> | |
102 | |
103 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
104 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transversions:</span></i><span | |
105 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
106 Shows the number of transversion mutations / the number of total mutations (the | |
107 percentage of mutations that are transitions). Transversion mutations are | |
108 C>A, C>G, T>A, T>G, A>T, A>C, G>T, G>C.</span></p> | |
109 | |
110 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
111 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions | |
112 at GC:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
113 font-family:"Times New Roman","serif"'> <a name="OLE_LINK2"></a><a | |
114 name="OLE_LINK1">Shows the number of transitions at GC locations (C>T, | |
115 G>A) / the total number of mutations at GC locations (the percentage of | |
116 mutations at GC locations that are transitions).</a></span></p> | |
117 | |
118 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
119 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Targeting | |
120 of GC:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
121 font-family:"Times New Roman","serif"'> <a name="OLE_LINK7"></a><a | |
122 name="OLE_LINK6"></a><a name="OLE_LINK3">Shows the number of mutations at GC | |
123 locations / the total number of mutations (the percentage of total mutations | |
124 that are at GC locations).</a> </span></p> | |
125 | |
126 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
127 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Transitions | |
128 at AT:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
129 font-family:"Times New Roman","serif"'> Shows the number of transitions at AT | |
130 locations (T>C, A>G) / the total number of mutations at AT locations (the | |
131 percentage of mutations at AT locations that are transitions).</span></p> | |
132 | |
133 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
134 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Targeting | |
135 of AT:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
136 font-family:"Times New Roman","serif"'> Shows the number of mutations at AT | |
137 locations / the total number of mutations (the percentage of total mutations | |
138 that are at AT locations).</span></p> | |
139 | |
140 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
141 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>RGYW:</span></i><span | |
142 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
143 <a name="OLE_LINK28"></a><a name="OLE_LINK27"></a><a name="OLE_LINK26">Shows | |
144 the number of mutations that are in a RGYW motive / The number of total mutations | |
145 (the percentage of mutations that are in a RGYW motive). </a><a | |
146 name="OLE_LINK62"></a><a name="OLE_LINK61">RGYW motives are known to be | |
147 preferentially targeted by AID </a></span><span lang=EN-GB style='font-size: | |
148 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine, | |
149 Y=pyrimidine, W = A or T).</span></p> | |
150 | |
151 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
152 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>WRCY:</span></i><span | |
153 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
154 <a name="OLE_LINK34"></a><a name="OLE_LINK33">Shows the number of mutations | |
155 that are in a </a><a name="OLE_LINK32"></a><a name="OLE_LINK31"></a><a | |
156 name="OLE_LINK30"></a><a name="OLE_LINK29">WRCY</a> motive / The number of | |
157 total mutations (the percentage of mutations that are in a WRCY motive). WRCY | |
158 motives are known to be preferentially targeted by AID </span><span lang=EN-GB | |
159 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine, | |
160 Y=pyrimidine, W = A or T).</span></p> | |
161 | |
162 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
163 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>WA:</span></i><span | |
164 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
165 <a name="OLE_LINK37"></a><a name="OLE_LINK36"></a><a name="OLE_LINK35">Shows | |
166 the number of mutations that are in a WA motive / The number of total mutations | |
167 (the percentage of mutations that are in a WA motive). It is described that | |
168 polymerase eta preferentially makes errors at WA motives </a></span><span | |
169 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(W | |
170 = A or T).</span></p> | |
171 | |
172 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
173 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>TW:</span></i><span | |
174 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
175 Shows the number of mutations that are in a TW motive / The number of total mutations | |
176 (the percentage of mutations that are in a TW motive). It is described that | |
177 polymerase eta preferentially makes errors at TW motives </span><span | |
178 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(W | |
179 = A or T).</span></p> | |
180 | |
181 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | |
182 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Antigen | |
183 selection:</span></u></p> | |
184 | |
185 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | |
186 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These | |
187 values give insight into antigen selection. It has been described that during | |
188 antigen selection, there is selection against replacement mutations in the FR | |
189 regions as these can cause instability of the B-cell receptor. In contrast | |
190 replacement mutations in the CDR regions are important for changing the | |
191 affinity of the B-cell receptor and therefore there is selection for this type | |
192 of mutations. Silent mutations do not alter the amino acid sequence and | |
193 therefore do not play a role in selection. More information on the values found | |
194 in healthy individuals of different ages can be found in IJspeert and van | |
195 Schouwenburg et al, PMID: 27799928</span></p> | |
196 | |
197 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
198 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>FR | |
199 R/S:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
200 font-family:"Times New Roman","serif"'> <a name="OLE_LINK43"></a><a | |
201 name="OLE_LINK42"></a><a name="OLE_LINK41">Shows the number of replacement | |
202 mutations in the FR regions / The number of silent mutations in the FR regions | |
203 (the number of replacement mutations in the FR regions divided by the number of | |
204 silent mutations in the FR regions)</a></span></p> | |
205 | |
206 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
207 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>CDR | |
208 R/S:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
209 font-family:"Times New Roman","serif"'> Shows the number of replacement | |
210 mutations in the CDR regions / The number of silent mutations in the CDR | |
211 regions (the number of replacement mutations in the CDR regions divided by the | |
212 number of silent mutations in the CDR regions)</span></p> | |
213 | |
214 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | |
215 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Number | |
216 of sequences nucleotides:</span></u></p> | |
217 | |
218 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | |
219 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These | |
220 values give information on the number of sequenced nucleotides.</span></p> | |
221 | |
222 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
223 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Nt | |
224 in FR:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
225 font-family:"Times New Roman","serif"'> <a name="OLE_LINK46"></a><a | |
226 name="OLE_LINK45"></a><a name="OLE_LINK44">Shows the number of sequences bases | |
227 that are located in the FR regions / The total number of sequenced bases (the | |
228 percentage of sequenced bases that are present in the FR regions).</a></span></p> | |
229 | |
230 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
231 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Nt | |
232 in CDR:</span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
233 font-family:"Times New Roman","serif"'> Shows the number of sequenced bases | |
234 that are located in the CDR regions / <a name="OLE_LINK48"></a><a | |
235 name="OLE_LINK47">The total number of sequenced bases (the percentage of | |
236 sequenced bases that are present in the CDR regions).</a></span></p> | |
237 | |
238 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
239 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>A: | |
240 </span></i><a name="OLE_LINK51"></a><a name="OLE_LINK50"></a><a | |
241 name="OLE_LINK49"><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
242 font-family:"Times New Roman","serif"'>Shows the total number of sequenced | |
243 adenines / The total number of sequenced bases (the percentage of sequenced | |
244 bases that were adenines).</span></a></p> | |
245 | |
246 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
247 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>C: | |
248 </span></i><a name="OLE_LINK53"></a><a name="OLE_LINK52"><span lang=EN-GB | |
249 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows | |
250 the total number of sequenced cytosines / The total number of sequenced bases | |
251 (the percentage of sequenced bases that were cytosines).</span></a></p> | |
252 | |
253 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
254 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>T: | |
255 </span></i><a name="OLE_LINK57"></a><a name="OLE_LINK56"><span lang=EN-GB | |
256 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows | |
257 the total number of sequenced </span></a><a name="OLE_LINK55"></a><a | |
258 name="OLE_LINK54"><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
259 font-family:"Times New Roman","serif"'>thymines</span></a><span lang=EN-GB | |
260 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'> | |
261 / The total number of sequenced bases (the percentage of sequenced bases that | |
262 were thymines).</span></p> | |
263 | |
264 <p class=MsoNormalCxSpMiddle style='text-align:justify'><i><span lang=EN-GB | |
265 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>G: | |
266 </span></i><span lang=EN-GB style='font-size:12.0pt;line-height:115%; | |
267 font-family:"Times New Roman","serif"'>Shows the total number of sequenced <a | |
268 name="OLE_LINK59"></a><a name="OLE_LINK58">guanine</a>s / The total number of | |
269 sequenced bases (the percentage of sequenced bases that were guanines).</span></p> | |
270 | |
271 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK69"><b><span | |
272 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Graphs</span></b></a></p> | |
273 | |
274 <p class=MsoNormalCxSpMiddle style='text-align:justify'><a name="OLE_LINK75"></a><a | |
275 name="OLE_LINK74"></a><a name="OLE_LINK73"><span lang=EN-GB style='font-size: | |
276 12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>These graphs visualize | |
277 information on the patterns and targeting of SHM and thereby give information | |
278 into the repair pathways used to repair the U:G mismatches introduced by AID. The | |
279 data represented in these graphs can be downloaded in the download tab. More | |
280 information on the values found in healthy individuals of different ages can be | |
281 found in IJspeert and van Schouwenburg et al, PMID: 27799928</span></a><span | |
282 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>. | |
283 <a name="OLE_LINK85"></a><a name="OLE_LINK84"></a></span></p> | |
284 | |
285 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | |
286 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Percentage | |
287 of mutations in AID and pol eta motives</span></u></p> | |
288 | |
289 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | |
290 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualizes | |
291 <a name="OLE_LINK80"></a><a name="OLE_LINK79"></a><a name="OLE_LINK78">for each | |
292 (sub)class </a>the percentage of mutations that are present in AID (RGYW or | |
293 WRCY) or polymerase eta motives (WA or TW) in the different subclasses </span><span | |
294 lang=EN-GB style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>(R=Purine, | |
295 Y=pyrimidine, W = A or T).</span></p> | |
296 | |
297 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=NL | |
298 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Relative | |
299 mutation patterns</span></u></p> | |
300 | |
301 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | |
302 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualizes | |
303 for each (sub)class the distribution of mutations between mutations at AT | |
304 locations and transitions or transversions at GC locations. </span></p> | |
305 | |
306 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=NL | |
307 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Absolute | |
308 mutation patterns</span></u></p> | |
309 | |
310 <p class=MsoNormalCxSpLast style='text-align:justify'><span lang=EN-GB | |
311 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Visualized | |
312 for each (sub)class the percentage of sequenced AT and GC bases that are | |
313 mutated. The mutations at GC bases are divided into transition and transversion | |
314 mutations<a name="OLE_LINK77"></a><a name="OLE_LINK76">. </a></span></p> | |
315 | |
316 <p class=MsoNormal><span lang=NL style='font-size:12.0pt;line-height:115%; | |
317 font-family:"Times New Roman","serif"'>Hanna IJspeert, Pauline A. van | |
318 Schouwenburg, David van Zessen, Ingrid Pico-Knijnenburg, Gertjan J. Driessen, | |
319 Andrew P. Stubbs, and Mirjam van der Burg (2016). </span><span | |
320 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Evaluation | |
321 of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and | |
322 Adults. In <i>Frontiers in Immunolog, 7, pp. e410-410. </i>[<a | |
323 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span | |
324 style='color:windowtext'>doi:10.3389/fimmu.2016.00410</span></a>][<a | |
325 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span | |
326 style='color:windowtext'>Link</span></a>]</span></p> | |
327 | |
328 </div> | |
329 | |
330 </body> | |
331 | |
332 </html> |